Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.695 USD | +15.83% | -0.67% | -41.12% |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 50.04M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 4.77 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.17 x |
P/E ratio 2024 * |
-1
x | P/E ratio 2025 * |
-2.64
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.96% |
Latest transcript on T2 Biosystems, Inc.
1 day | +15.83% | ||
1 week | -0.67% | ||
Current month | +10.13% | ||
1 month | +17.30% | ||
3 months | -24.44% | ||
6 months | -21.72% | ||
Current year | -41.12% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.695 | +15.83% | 1,071,489 |
24-05-09 | 3.19 | +4.59% | 671,917 |
24-05-08 | 3.05 | -5.86% | 488,190 |
24-05-07 | 3.24 | -10.74% | 896,563 |
24-05-06 | 3.63 | -2.42% | 903,568 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.12% | 50.04M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- TTOO Stock